TLON Feuerstein: FDA Raises Safety Questions on Talon Therapeutic's Drug Posted on 03/19/12 at 10:26am by Allie Wickman [1]
Notable biotech analyst Adam Feuerstein tweeted [2] on Monday about Talon Therapeutics (OTC: TLON [3]) and how the FDA rose questions regarding safety about Marqibo-associated peripheral neuropathy.
He said via Twitter, $TLON - FDA raises safety questions about Marqibo-associated peripheral neuropathy, notes 15 patients died on treatment".
Currently, shares of Talon are trading up about 2% on the session at $0.99 per share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.